Newer vascular targets: endosialin (review)

Beverly A Teicher1

  • 1Genzyme Corporation, Framingham, MA 01701-9322, USA. beverly.teicher@genzyme.com

Summary

Identifying specific markers on tumor blood vessels is difficult. Researchers found endosialin, a cell surface protein, is selectively expressed on tumor vasculature and stroma, offering potential for cancer therapy.